New method discovered to halt active cancer cells
Scientists have discovered a way to stop active cancer cells in their tracks – meaning they can then be eliminated by new drug treatments.
A collaborative research project between the University of Dundee’s Drug Discovery Unit (DDU) and Queen Mary University of London, has identified chemical compounds, called tool molecules, that can halt active cancer cells.
Using these tool molecules forces tumour cells from a specific type of breast cancer into a pro-senescence state – similar to a sleep-like state in which they can no longer divide or cause tumour growth.
This condition makes the cancer cells sensitive to a second group of tool molecules, called senolytic drugs, which can eliminate them. It may also ‘uncloak’ the cancer cells, making them visible to the body’s immune system, offering further therapeutic opportunities.
Researchers developed this ‘two-punch’ method while looking at basal-like breast cancer (BLBC).
A team funded by Barts Charity, and led by Cleo Bishop, Professor of Senescence at Queen Mary University of London and Academic Lead for the Phenotypic Screening Facility, uncovered a pathway to force BLBC cells into pro-senescence.
They then collaborated with another team based at the University of Dundee’s Drug Discovery Unit (DDU) to develop tool molecules to promote senescence within the cells.
More information from Dundee University click here.